Resource Filter: Specimen
Development of WTX-712, a Conditionally Active IL-21 INDUKINETM Molecule for the Treatment of Cancer
Date
The Combination of ACT and INDUKINE™ Therapy Leads to Improved Antitumor Immunity in Mouse Solid Tumors
Date
Spatial Analysis of Tumor Infiltrating Lymphocyte Populations in Syngeneic Mouse Tumor Models After Treatment with IL-12 (mWTX-330) or IL-2 (WTX-124) INDUKINE™ Molecules
Date
Super-enhancer hijacking drives ectopic expression of hedgehog pathway ligands in meningiomas
Date
Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance
Date
Fully Automated Sequential Immunofluorescence (seqIF) for Hyperplex Spatial Proteomics
Date
Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytoma
Date
Targeted removal of macrophage-secreted interleukin-1 receptor antagonist protects against lethal Candida albicans sepsis
Date
Inflammation induced by tumor-associated nerves promotes resistance to anti-PD-1 therapy in cancer patients and is targetable by IL-6 blockade
Date
Studying the immune status of the tumor microenvironment with automated hyperplex immunofluorescence
Date
